116th CONGRESS 1st Session |
July 24, 2019
Received; read twice and referred to the Committee on Commerce, Science, and Transportation
To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title; findings.
(a) Short title.—This Act may be cited as the “Expanding Findings for Federal Opioid Research and Treatment Act” or the “EFFORT Act”.
(b) Findings.—The Congress finds that—
(1) research gaps currently exist in the prevention and treatment of opioid addiction;
(2) the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and
(3) the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.
SEC. 2. NSF support of research on opioid addiction.
The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction.
Passed the House of Representatives July 23, 2019.
Attest: | cheryl l. johnson, |
Clerk. |